Acquisitions in Global Antiepileptic Drugs Market trends to 2020

1
Global Antiepileptic Drugs Market (Drug Type and
Geography) 2013-2020 www.bigmarketresearch.com
2
Report Description
Antiepileptic drugs (AEDs) are commonly termed
as anticonvulsants or antiseizure drugs, which
are used in symptomatic treatment of epileptic
seizures. The epileptic seizures show recurring
episodes and occur due to wrong signal sent by
nerve cells to the brain. Antiepileptic drugs
also act as mood stabilizers and also used in the
treatment of bipolar disorders or neuropathic
pain. Antiepileptics market is specifically
driven due to new drug approvals over the past
few years. However, recent patent expiration of
major brand such as Lamictal is expected to
hinder the growth of the market. GlaxoSmithKline,
Johnson Johnson, Sanofi, Pfizer, Novartis,
Abbott, Sunovion Pharmaceuticals, and Cephalon
are some of the key leaders of global
antiepileptic drugs market. Generic competition
has dramatically increased for antiepileptics due
to patent expiration of major brands and in
future, it would be responsible for down pricing
of branded drugs. Lyrica was the largest selling
antiepileptic brand owing to its highly
efficacious nature. Retigabine and perampanel are
recently approved antiepileptics, which act
through new molecular targets. Browse complete
report _at_ http//www.bigmarketresearch.com/antiep
ileptic-drugs-market
3
Report Description
Antiepileptic drugs market is segmented based on
drug type and geography. Drug type segment is
further categorized into two broad categories,
namely first and second-generation antiepileptic
drugs. Phenytoin, carbamazepine, oxycarbazepine
and valproate from the first generation class,
dominates the overall antiepileptics market. From
the second-generation drugs, zonisamide,
levetiracetam, and lacosamide are gaining
popularity due to their tolerability and high
efficacy. Geographically, global antiepileptic
drugs market is segmented into North America,
Europe, Asia-Pacific and LAMEA. North America and
Europe dominates the global market due to
extensive RD efforts and presence of approved
second-generation antiepileptics. Asia-pacific is
the fastest growing market owing to widespread
prevalence of epilepsy and better penetration of
antiepileptic drugs. In-depth coverage of the
global antiepileptic drugs market including
drivers, restraints and opportunities would help
professionals to better understand market
behavior. Porters Five Forces analysis examines
the competitive structure of the global
antiepileptic drugs market and it would assist
market strategists in their respective decision
making process. Feel free to get enquire about
report _at_ http//www.bigmarketresearch.com/report
-enquiry/22983
4
Report Description

• KEY BENEFITS
• This report offers the following benefits in
  particular
• In-depth coverage of the global antiepileptic
  drugs market including drivers, restraints and
  opportunities would help professionals to better
  understand market behavior
• Porters Five Forces analysis examines the
  competitive structure of the global antiepileptic
  drugs market and it would assist market
  strategists in their respective decision making
  process
• Pinpointed analysis of geographic segments helps
  to identify opportunities for growth within the
  global antiepileptic drugs market
• Detailed study of the strategies of key leaders,
  partnerships and acquisitions in the global
  antiepileptic drugs market would be informative
  for professionals in the corporate sector

5
Report Description

• KEY MARKET SEGMENTS
• The global antiepileptic drugs market is
  segmented into two major categories such as drug
  type and geography.
• MARKET BY DRUG TYPE
• First Generation AEDs
• Phenytoin (Dilantin, Phenytek)
• Carbamazepine (Carbatrol)
• Oxycarbazepine (Trileptal)
• Valproate (Depakote)
• Topiramate (Topamax)
• Ethosuximide (Zarontin)
• Primidone (Mysoline)
• Phenobarbital (Luminal)
• Second Generation AEDs
• Lamotrigine (Lamictal)

6
Report Description

• Pregabalin (Lyrica)
• Rufinamide (Banzel/Inovelon)
• Levetiracetam (Keppra)
• Ezogabine/retigabine (Trobalt/Potiga)
• Lacosamide (Vimpat)
• Eslicarbazepine acetate (Aptiom)
• Zonisamide (Zonegran)
• Perampanel (Fycompa)
• MARKET BY GEOGRAPHY
• North America
• Europe
• Asia-Pacific
• LAMEA
• Request for the Table of Contents _at_
• http//www.bigmarketresearch.com/antiepileptic-dru
  gs-market

7
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/antiepileptic-dru
gs-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone]E-MAIL
help_at_bigmarketresearch.com